Literature DB >> 28994344

Phase-I randomized trial of doxorubicin hydrochloride liposome injection versus Caelyx® in multiple myeloma.

Shravanti Bhowmik1, Subhas Bhowmick2, Kuntal Maiti1, Amaresh Chakra2, Pradeep Shahi2, Thennati Rajamannar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28994344     DOI： 10.1080/10428194.2017.1382692

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment.

Authors:  Ning Tian; Dongmei Wang; Xiaobao Li; Minghua Xue; Bo Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.